Om

Mauna Kea Technologies SA is a French medical technology company focused on real-time in vivo cellular imaging for minimally invasive procedures. The company develops and commercializes optical biopsy systems built around its Cellvizio platform, which provides physicians with microscopic views of tissue during endoscopy and other clinical interventions. Its solutions are used in gastroenterology, pulmonology, and urology, supporting the visualization and detection of cellular abnormalities, particularly in cancer-related care. Mauna Kea Technologies SA serves hospitals, specialists, and researchers who need advanced imaging tools to improve clinical decision-making within procedural workflows. Headquartered in Paris, the company plays a niche role in the medical device market by combining imaging technology with diagnostic and therapeutic applications.

Analytikerskøn

Baseret på 1 analytiker

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I MAUNA KEA TECHNOLOGIES MED ENDAVU: Køb Mauna Kea Technologies ($ALMKT) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Mauna Kea Technologies, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.